{
  "issues": [
    "Renal tool summary lists 'Missing BMI or creatinine' despite creatinine being present, indicating a logic inconsistency.",
    "Renal tool reports 'No lab timestamps provided' even though timestamps exist for each check; lab timing information is missing from the input data.",
    "Renal tool does not incorporate the patient’s profound hypotension (SBP 78 mmHg, MAP 49 mmHg) and tachycardia into its risk assessment, which is critical for contrast safety decisions.",
    "Agent 2 recommendations omit specifics on contrast type (iso‑osmolar vs low‑osmolar) and hydration strategy for a volume‑depleted, hypotensive patient.",
    "Agent 2 does not address the potential benefit of low‑kVp, high‑pitch CT acquisition techniques that can further reduce iodine load.",
    "Hemoglobin is low (10.3 g/dL); no comment on bleeding risk or need for hemostatic optimization before contrast administration."
  ],
  "recommendations": [
    "Update the renal decision tool to: (a) include BMI calculation from height/weight data; (b) accept and store lab timestamps; (c) flag hemodynamic instability (SBP <90 mmHg, MAP <65 mmHg) as an additional high‑risk factor for contrast‑induced nephropathy.",
    "For the CT angiography, use a weight‑based, low‑volume iodine load (≈80 mL) of iso‑osmolar contrast if the patient is volume‑depleted; otherwise use low‑osmolar contrast with the lowest feasible concentration.",
    "Implement a pre‑contrast hydration protocol (e.g., 1 mL/kg/hour isotonic saline for 6–12 hours) if the patient’s volume status allows, or a cautious bolus if hypotension precludes prolonged fluids.",
    "Employ low‑kVp (80–100 kVp) and high‑pitch dual‑source CT acquisition to maintain image quality while reducing required iodine dose.",
    "Ensure rapid transport with continuous hemodynamic monitoring; consider a bedside TEE or focused cardiac ultrasound if transport is unsafe despite attempts at stabilization.",
    "Obtain baseline urine output and consider a post‑contrast urine output target (>0.5 mL/kg/h) as part of AKI monitoring.",
    "Schedule serum creatinine and eGFR checks at 24 h and 48 h post‑contrast, and repeat hemoglobin to assess for occult bleeding.",
    "Document fluid balance and consider blood product support if hemoglobin falls <9 g/dL before or after imaging."
  ],
  "confidence": 0.78,
  "agent2_confidence": 0.9,
  "timestamp": "2025-09-05T13:49:42.515052Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-09-05T13:49:33.041313Z",
          "priority": "critical",
          "value": 135.1,
          "status": "pass",
          "reason": "Low renal risk for contrast."
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-09-05T13:49:33.041324Z",
          "priority": "critical",
          "value": 0.5,
          "status": "pass",
          "reason": "Creatinine within normal range."
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-09-05T13:49:33.041329Z",
          "priority": "important",
          "value": 16.0,
          "status": "pass",
          "reason": "BUN/Cr ratio normal."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-09-05T13:49:33.041341Z",
          "priority": "important",
          "value": 3.6,
          "status": "pass",
          "reason": "Potassium normal."
        }
      ],
      "summary": {
        "overall": "pass",
        "reasons": [
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.92
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-09-05T13:49:33.041364Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Renal tool summary lists 'Missing BMI or creatinine' despite creatinine being present, indicating a logic inconsistency.\",\n    \"Renal tool reports 'No lab timestamps provided' even though timestamps exist for each check; lab timing information is missing from the input data.\",\n    \"Renal tool does not incorporate the patient’s profound hypotension (SBP 78 mmHg, MAP 49 mmHg) and tachycardia into its risk assessment, which is critical for contrast safety decisions.\",\n    \"Agent 2 recommendations omit specifics on contrast type (iso‑osmolar vs low‑osmolar) and hydration strategy for a volume‑depleted, hypotensive patient.\",\n    \"Agent 2 does not address the potential benefit of low‑kVp, high‑pitch CT acquisition techniques that can further reduce iodine load.\",\n    \"Hemoglobin is low (10.3 g/dL); no comment on bleeding risk or need for hemostatic optimization before contrast administration.\"\n  ],\n  \"recommendations\": [\n    \"Update the renal decision tool to: (a) include BMI calculation from height/weight data; (b) accept and store lab timestamps; (c) flag hemodynamic instability (SBP <90 mmHg, MAP <65 mmHg) as an additional high‑risk factor for contrast‑induced nephropathy.\",\n    \"For the CT angiography, use a weight‑based, low‑volume iodine load (≈80 mL) of iso‑osmolar contrast if the patient is volume‑depleted; otherwise use low‑osmolar contrast with the lowest feasible concentration.\",\n    \"Implement a pre‑contrast hydration protocol (e.g., 1 mL/kg/hour isotonic saline for 6–12 hours) if the patient’s volume status allows, or a cautious bolus if hypotension precludes prolonged fluids.\",\n    \"Employ low‑kVp (80–100 kVp) and high‑pitch dual‑source CT acquisition to maintain image quality while reducing required iodine dose.\",\n    \"Ensure rapid transport with continuous hemodynamic monitoring; consider a bedside TEE or focused cardiac ultrasound if transport is unsafe despite attempts at stabilization.\",\n    \"Obtain baseline urine output and consider a post‑contrast urine output target (>0.5 mL/kg/h) as part of AKI monitoring.\",\n    \"Schedule serum creatinine and eGFR checks at 24 h and 48 h post‑contrast, and repeat hemoglobin to assess for occult bleeding.\",\n    \"Document fluid balance and consider blood product support if hemoglobin falls <9 g/dL before or after imaging.\"\n  ],\n  \"confidence\": 0.88\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Renal tool summary lists 'Missing BMI or creatinine' despite creatinine being present, indicating a logic inconsistency.",
        "type": "issue",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Renal tool reports 'No lab timestamps provided' even though timestamps exist for each check; lab timing information is missing from the input data.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Renal tool does not incorporate the patient’s profound hypotension (SBP 78 mmHg, MAP 49 mmHg) and tachycardia into its risk assessment, which is critical for contrast safety decisions.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '78'"
      },
      {
        "text": "Agent 2 recommendations omit specifics on contrast type (iso‑osmolar vs low‑osmolar) and hydration strategy for a volume‑depleted, hypotensive patient.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Agent 2 does not address the potential benefit of low‑kVp, high‑pitch CT acquisition techniques that can further reduce iodine load.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Hemoglobin is low (10.3 g/dL); no comment on bleeding risk or need for hemostatic optimization before contrast administration.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '10.3'"
      },
      {
        "text": "Update the renal decision tool to: (a) include BMI calculation from height/weight data; (b) accept and store lab timestamps; (c) flag hemodynamic instability (SBP <90 mmHg, MAP <65 mmHg) as an additional high‑risk factor for contrast‑induced nephropathy.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "For the CT angiography, use a weight‑based, low‑volume iodine load (≈80 mL) of iso‑osmolar contrast if the patient is volume‑depleted; otherwise use low‑osmolar contrast with the lowest feasible concentration.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Implement a pre‑contrast hydration protocol (e.g., 1 mL/kg/hour isotonic saline for 6–12 hours) if the patient’s volume status allows, or a cautious bolus if hypotension precludes prolonged fluids.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Employ low‑kVp (80–100 kVp) and high‑pitch dual‑source CT acquisition to maintain image quality while reducing required iodine dose.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Ensure rapid transport with continuous hemodynamic monitoring; consider a bedside TEE or focused cardiac ultrasound if transport is unsafe despite attempts at stabilization.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Obtain baseline urine output and consider a post‑contrast urine output target (>0.5 mL/kg/h) as part of AKI monitoring.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0.5'"
      },
      {
        "text": "Schedule serum creatinine and eGFR checks at 24 h and 48 h post‑contrast, and repeat hemoglobin to assess for occult bleeding.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Document fluid balance and consider blood product support if hemoglobin falls <9 g/dL before or after imaging.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      }
    ],
    "counts": {
      "supported": 13,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 1,
      "contradicted": 0
    },
    "hallucination_score": 0.036,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.1
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 10014729.0,
        "hadm_id": 28889419.0,
        "stay_id": 33558396.0,
        "age": 21.0,
        "hospital_expire_flag": 0.0,
        "los_hospital_days": 2.47,
        "los_icu_days": 2.47,
        "creatinine_mg_dl": 0.5,
        "bun_mg_dl": 8.0,
        "glucose_mg_dl": 76.0,
        "hemoglobin_g_dl": 10.3,
        "hematocrit_pct": 29.9,
        "platelet_count": 229.0,
        "wbc_count": 6.9,
        "sodium_meq_l": 137.0,
        "potassium_mmol_l": 3.6,
        "chloride_meq_l": 97.0,
        "bicarbonate_meq_l": 25.0,
        "egfr_ckd_epi": 135.1,
        "ckd_stage": 1.0,
        "bun_creatinine_ratio": 16.0,
        "heart_rate_bpm": 107.0,
        "systolic_bp_mmhg": 78.0,
        "diastolic_bp_mmhg": 35.0,
        "map_mmhg": 49.3,
        "pulse_pressure_mmhg": 43.0,
        "temperature_f": 99.1,
        "spo2_pct": 98.0,
        "respiratory_rate": 18.0,
        "data_completeness_pct": 0.95
      },
      "raw_strings_sample": [
        "25.0",
        "49.3",
        "potassium normal.",
        "18",
        "creatinine_mg_dl",
        "potassium_mmol_l",
        "10.3",
        "33558396",
        "76.0",
        "bun_creatinine_ratio"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Renal tool summary lists 'Missing BMI or creatinine' despite creatinine being present, indicating a logic inconsistency.",
      "Renal tool reports 'No lab timestamps provided' even though timestamps exist for each check; lab timing information is missing from the input data.",
      "Renal tool does not incorporate the patient’s profound hypotension (SBP 78 mmHg, MAP 49 mmHg) and tachycardia into its risk assessment, which is critical for contrast safety decisions.",
      "Agent 2 recommendations omit specifics on contrast type (iso‑osmolar vs low‑osmolar) and hydration strategy for a volume‑depleted, hypotensive patient.",
      "Agent 2 does not address the potential benefit of low‑kVp, high‑pitch CT acquisition techniques that can further reduce iodine load.",
      "Hemoglobin is low (10.3 g/dL); no comment on bleeding risk or need for hemostatic optimization before contrast administration."
    ],
    "recommendations": [
      "Update the renal decision tool to: (a) include BMI calculation from height/weight data; (b) accept and store lab timestamps; (c) flag hemodynamic instability (SBP <90 mmHg, MAP <65 mmHg) as an additional high‑risk factor for contrast‑induced nephropathy.",
      "For the CT angiography, use a weight‑based, low‑volume iodine load (≈80 mL) of iso‑osmolar contrast if the patient is volume‑depleted; otherwise use low‑osmolar contrast with the lowest feasible concentration.",
      "Implement a pre‑contrast hydration protocol (e.g., 1 mL/kg/hour isotonic saline for 6–12 hours) if the patient’s volume status allows, or a cautious bolus if hypotension precludes prolonged fluids.",
      "Employ low‑kVp (80–100 kVp) and high‑pitch dual‑source CT acquisition to maintain image quality while reducing required iodine dose.",
      "Ensure rapid transport with continuous hemodynamic monitoring; consider a bedside TEE or focused cardiac ultrasound if transport is unsafe despite attempts at stabilization.",
      "Obtain baseline urine output and consider a post‑contrast urine output target (>0.5 mL/kg/h) as part of AKI monitoring.",
      "Schedule serum creatinine and eGFR checks at 24 h and 48 h post‑contrast, and repeat hemoglobin to assess for occult bleeding.",
      "Document fluid balance and consider blood product support if hemoglobin falls <9 g/dL before or after imaging."
    ],
    "confidence": 0.78
  }
}